$TEVA

2022 Q2 Form 10-Q Financial Statement

#000119312522203392 Filed on July 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q4 2021 Q2
Revenue $3.786B $4.100B $3.910B
YoY Change -3.17% -7.93% 1.03%
Cost Of Revenue $1.992B $1.975B $2.037B
YoY Change -2.21% -16.74% -2.58%
Gross Profit $1.794B $2.125B $1.873B
YoY Change -4.22% 2.11% 5.28%
Gross Profit Margin 47.39% 51.83% 47.9%
Selling, General & Admin $907.0M $858.0M $857.0M
YoY Change 5.83% -11.09% 4.13%
% of Gross Profit 50.56% 40.38% 45.76%
Research & Development $228.0M $249.0M $248.0M
YoY Change -8.06% 2.48%
% of Gross Profit 12.71% 11.72% 13.24%
Depreciation & Amortization $358.0M $320.0M $305.0M
YoY Change 17.38% -18.99% -20.16%
% of Gross Profit 19.96% 15.06% 16.28%
Operating Expenses $1.135B $1.154B $1.105B
YoY Change 2.71% -11.16% 1.38%
Operating Profit -$949.0M $971.0M $582.0M
YoY Change -263.06% 24.17% -15.53%
Interest Expense -$225.0M -$170.0M -$254.0M
YoY Change -11.42% -0.58% 8.09%
% of Operating Profit -17.51% -43.64%
Other Income/Expense, Net -$211.0M -$83.00M -$274.0M
YoY Change -22.99% -14.43% -2590.91%
Pretax Income -$1.160B -$175.0M $308.0M
YoY Change -476.62% -227.74% -703.92%
Income Tax -$900.0M -$24.00M $98.00M
% Of Pretax Income 31.82%
Net Earnings -$232.0M -$158.0M $207.0M
YoY Change -212.08% -206.04% 47.86%
Net Earnings / Revenue -6.13% -3.85% 5.29%
Basic Earnings Per Share -$0.21 $0.19
Diluted Earnings Per Share -$0.21 -$143.4K $0.19
COMMON SHARES
Basic Shares Outstanding 1.110B 1.103B
Diluted Shares Outstanding 1.110B 1.109B

Balance Sheet

Concept 2022 Q2 2021 Q4 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.058B $2.165B $2.436B
YoY Change -15.52% -0.55% 1.42%
Cash & Equivalents $2.058B $2.165B $2.436B
Short-Term Investments
Other Short-Term Assets $518.0M $965.0M $1.536B
YoY Change -66.28% -47.67% 4.28%
Inventory $4.049B $3.818B $4.362B
Prepaid Expenses $1.052B $1.075B
Receivables $4.471B $4.529B $4.488B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.16B $12.57B $12.82B
YoY Change -5.13% -3.32% 0.32%
LONG-TERM ASSETS
Property, Plant & Equipment $5.740B $5.982B $6.658B
YoY Change -13.79% -12.74% 0.71%
Goodwill $18.84B $20.04B $20.42B
YoY Change -7.76% -2.83% -17.04%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $454.0M $515.0M $1.174B
YoY Change -61.33% -58.23% 12.56%
Total Long-Term Assets $33.77B $35.09B $36.37B
YoY Change -7.16% -6.75% -13.83%
TOTAL ASSETS
Total Short-Term Assets $12.16B $12.57B $12.82B
Total Long-Term Assets $33.77B $35.09B $36.37B
Total Assets $45.93B $47.67B $49.20B
YoY Change -6.63% -5.87% -10.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.901B $1.686B $1.551B
YoY Change 22.57% -3.99% -3.42%
Accrued Expenses $2.579B $2.771B $2.318B
YoY Change 11.26% 7.36% 0.83%
Deferred Revenue
YoY Change
Short-Term Debt $23.00M $23.00M $23.00M
YoY Change 0.0% -95.53% -95.52%
Long-Term Debt Due $1.696B $1.403B $3.507B
YoY Change -51.64% -47.53% 208.71%
Total Short-Term Liabilities $11.00B $11.03B $12.69B
YoY Change -13.36% -16.23% 8.0%
LONG-TERM LIABILITIES
Long-Term Debt $20.36B $21.62B $21.60B
YoY Change -5.74% -4.9% -12.24%
Other Long-Term Liabilities $3.842B $2.578B $2.659B
YoY Change 44.49% -5.22% -5.88%
Total Long-Term Liabilities $25.11B $25.40B $24.26B
YoY Change 3.49% -0.22% -11.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.00B $11.03B $12.69B
Total Long-Term Liabilities $25.11B $25.40B $24.26B
Total Liabilities $36.10B $36.42B $38.87B
YoY Change -7.12% -10.32% -5.51%
SHAREHOLDERS EQUITY
Retained Earnings -$11.72B -$10.53B
YoY Change
Common Stock $57.00M $57.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.128B $4.128B
YoY Change
Treasury Stock Shares $106.0M $106.0M
Shareholders Equity $9.037B $10.28B $10.32B
YoY Change
Total Liabilities & Shareholders Equity $45.93B $47.67B $49.20B
YoY Change -6.63% -5.87% -10.54%

Cashflow Statement

Concept 2022 Q2 2021 Q4 2021 Q2
OPERATING ACTIVITIES
Net Income -$232.0M -$158.0M $207.0M
YoY Change -212.08% -206.04% 47.86%
Depreciation, Depletion And Amortization $358.0M $320.0M $305.0M
YoY Change 17.38% -18.99% -20.16%
Cash From Operating Activities $122.0M $456.0M $218.0M
YoY Change -44.04% 37.76% -20.15%
INVESTING ACTIVITIES
Capital Expenditures -$127.0M -$153.0M -$113.0M
YoY Change 12.39% -13.07% -13.74%
Acquisitions $0.00
YoY Change
Other Investing Activities $307.0M $399.0M $594.0M
YoY Change -48.32% 25.87% 33.78%
Cash From Investing Activities $180.0M $246.0M $481.0M
YoY Change -62.58% 74.47% 53.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $296.0M
YoY Change
Cash From Financing Activities -338.0M -501.0M -1.000M
YoY Change 33700.0% 300.8% -66.67%
NET CHANGE
Cash From Operating Activities 122.0M 456.0M 218.0M
Cash From Investing Activities 180.0M 246.0M 481.0M
Cash From Financing Activities -338.0M -501.0M -1.000M
Net Change In Cash -36.00M 201.0M 698.0M
YoY Change -105.16% -42.07% 19.73%
FREE CASH FLOW
Cash From Operating Activities $122.0M $456.0M $218.0M
Capital Expenditures -$127.0M -$153.0M -$113.0M
Free Cash Flow $249.0M $609.0M $331.0M
YoY Change -24.77% 20.12% -18.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
173000000
CY2022Q2 us-gaap Inventory Net
InventoryNet
4049000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3818000000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1052000000
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000818686
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Address Country
EntityAddressCountry
IL
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16174
dei Entity Registrant Name
EntityRegistrantName
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
dei Entity Address Address Line1
EntityAddressAddressLine1
124 Dvora HaNevi’a St.
dei Entity Address City Or Town
EntityAddressCityOrTown
Tel Aviv
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6944020
dei City Area Code
CityAreaCode
3
dei Local Phone Number
LocalPhoneNumber
914-8213
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing one Ordinary Share
dei Trading Symbol
TradingSymbol
TEVA
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1110564656
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2058000000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2165000000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
95000000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90000000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4471000000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4529000000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1075000000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
518000000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
965000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7447000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7892000000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-232000000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
207000000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2091000000
us-gaap Net Income Loss
NetIncomeLoss
-1187000000
us-gaap Net Income Loss
NetIncomeLoss
284000000
CY2022Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
16000000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19000000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25107000000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
12164000000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12573000000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1595000000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
596000000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
454000000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
515000000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5740000000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5982000000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
441000000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
495000000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6700000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7466000000
CY2022Q2 us-gaap Goodwill
Goodwill
18837000000
CY2021Q4 us-gaap Goodwill
Goodwill
20040000000
CY2022Q2 us-gaap Assets
Assets
45932000000
CY2021Q4 us-gaap Assets
Assets
47666000000
CY2022Q2 us-gaap Debt Current
DebtCurrent
1719000000
CY2021Q4 us-gaap Debt Current
DebtCurrent
1426000000
CY2022Q2 teva Sales Reserves And Allowances
SalesReservesAndAllowances
3880000000
CY2021Q4 teva Sales Reserves And Allowances
SalesReservesAndAllowances
4241000000
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1901000000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1686000000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
467000000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
563000000
CY2022Q2 teva Accrued Expenses
AccruedExpenses
2112000000
CY2021Q4 teva Accrued Expenses
AccruedExpenses
2208000000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
916000000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
903000000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10996000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11027000000
CY2022Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
532000000
CY2021Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
784000000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3842000000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2578000000
CY2022Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
20363000000
CY2021Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
21617000000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
371000000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
416000000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25395000000
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Liabilities
Liabilities
36103000000
CY2021Q4 us-gaap Liabilities
Liabilities
36422000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4141000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2022Q2 us-gaap Gross Profit
GrossProfit
1794000000
CY2021Q2 us-gaap Gross Profit
GrossProfit
1873000000
us-gaap Gross Profit
GrossProfit
3534000000
us-gaap Gross Profit
GrossProfit
3750000000
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
228000000
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
248000000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
453000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
609000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
532000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2495
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2495
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1216
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1209
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
57000000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
57000000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27625000000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27561000000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11716000000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10529000000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2801000000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2683000000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
106000000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
106000000
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
4128000000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4128000000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
9037000000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10278000000
CY2022Q2 us-gaap Minority Interest
MinorityInterest
791000000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
966000000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9828000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11244000000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45932000000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47666000000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3786000000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3910000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7447000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7892000000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1992000000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2037000000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3913000000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
501000000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
594000000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
615000000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1178000000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1200000000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
313000000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
242000000
CY2022Q2 teva Intangible Assets Impairments
IntangibleAssetsImpairments
51000000
CY2021Q2 teva Intangible Assets Impairments
IntangibleAssetsImpairments
195000000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-259000000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11000000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
14000000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
teva Intangible Assets Impairments
IntangibleAssetsImpairments
199000000
teva Intangible Assets Impairments
IntangibleAssetsImpairments
274000000
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q2 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
118000000
CY2021Q2 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
28000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
246000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
165000000
CY2022Q2 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
729000000
CY2021Q2 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
6000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
1854000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
110000000
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
34000000
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
43000000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
87000000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
48000000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-949000000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
582000000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1662000000
us-gaap Operating Income Loss
OperatingIncomeLoss
1015000000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-211000000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-274000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-468000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-564000000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1160000000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
308000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2131000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
451000000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-899000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159000000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
221000000
us-gaap Profit Loss
ProfitLoss
-1211000000
us-gaap Profit Loss
ProfitLoss
306000000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27000000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14000000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24000000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21000000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1479000000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
191000000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-125000000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2436000000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
13000000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-174000000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-212000000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39000000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-47000000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9828000000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1110000000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1103000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1109000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1101000000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1110000000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1108000000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-259000000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
221000000
us-gaap Profit Loss
ProfitLoss
-1211000000
us-gaap Profit Loss
ProfitLoss
306000000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-219000000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
79000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-282000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-130000000
CY2022Q2 teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
7000000
CY2021Q2 teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
7000000
teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
14000000
teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
14000000
CY2022Q2 us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
0
CY2021Q2 us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
1000000
us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
0
us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
1000000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-212000000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
87000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-268000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-115000000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-471000000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
308000000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-346000000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
295000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1305000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
238000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10260000000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-259000000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10975000000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
221000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11311000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11244000000
us-gaap Profit Loss
ProfitLoss
-1211000000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
491000000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
87000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-268000000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
296000000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2058000000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2436000000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
989000000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
33000000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9828000000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11061000000
us-gaap Profit Loss
ProfitLoss
306000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-115000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60000000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11311000000
us-gaap Profit Loss
ProfitLoss
-1211000000
us-gaap Profit Loss
ProfitLoss
306000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
681000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
681000000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
975000000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
354000000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-913000000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
1679000000
teva Deferred Income Taxes Net And Uncertain Tax Positions
DeferredIncomeTaxesNetAndUncertainTaxPositions
-1258000000
teva Deferred Income Taxes Net And Uncertain Tax Positions
DeferredIncomeTaxesNetAndUncertainTaxPositions
5000000
us-gaap Share Based Compensation
ShareBasedCompensation
63000000
us-gaap Share Based Compensation
ShareBasedCompensation
60000000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-77000000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-7000000
teva Profit From Sale Of Long Lived Assets And Investment
ProfitFromSaleOfLongLivedAssetsAndInvestment
12000000
teva Profit From Sale Of Long Lived Assets And Investment
ProfitFromSaleOfLongLivedAssetsAndInvestment
-93000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-187000000
teva Proceeds From Beneficial Interest In Exchange For Securitized Trade Receivables
ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables
592000000
teva Proceeds From Beneficial Interest In Exchange For Securitized Trade Receivables
ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables
881000000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
43000000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
254000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
284000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
263000000
teva Payment To Acquire Marketable Securities And Other Assets
PaymentToAcquireMarketableSecuritiesAndOtherAssets
4000000
teva Payment To Acquire Marketable Securities And Other Assets
PaymentToAcquireMarketableSecuritiesAndOtherAssets
36000000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3000000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
153000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
341000000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-40000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-336000000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
86000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-494000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-185000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-49000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-107000000
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
259000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2198000000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
7000000
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-30000000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2177000000
CY2021 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-76000000
CY2022Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
16000000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
0
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
2000000
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
46000000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3786000000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3910000000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2091000000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2436000000
CY2022Q2 teva Beneficial Interest Obtained In Exchange For Securitized Trade Receivables
BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables
590000000
CY2021Q2 teva Beneficial Interest Obtained In Exchange For Securitized Trade Receivables
BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables
878000000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19000000
CY2022Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
43000000
CY2022Q2 us-gaap Other Inventory In Transit
OtherInventoryInTransit
204000000
CY2021Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
163000000
CY2022Q2 us-gaap Senior Notes
SeniorNotes
22144000000
CY2022Q2 us-gaap Inventory Net
InventoryNet
4049000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3818000000
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4309000000
teva Valuation Allowances And Reserves Related To Current Period Sales
ValuationAllowancesAndReservesRelatedToCurrentPeriodSales
6651000000
teva Valuation Allowances And Reserves Related To Prior Period Sales
ValuationAllowancesAndReservesRelatedToPriorPeriodSales
-108000000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
6861000000
teva Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-47000000
CY2022Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3944000000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4904000000
teva Valuation Allowances And Reserves Related To Current Period Sales
ValuationAllowancesAndReservesRelatedToCurrentPeriodSales
7037000000
teva Valuation Allowances And Reserves Related To Prior Period Sales
ValuationAllowancesAndReservesRelatedToPriorPeriodSales
-196000000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
7209000000
teva Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-12000000
CY2021Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4524000000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1875000000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1932000000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1346000000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1136000000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
624000000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
587000000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1696000000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1403000000
CY2022Q2 us-gaap Debt Current
DebtCurrent
1719000000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19092000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19982000000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12392000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12516000000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6700000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7466000000
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
212000000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
173000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
412000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
414000000
CY2022Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
51000000
CY2021Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
195000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
199000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
274000000
CY2021Q4 us-gaap Goodwill
Goodwill
20040000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12000000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
470000000
CY2022Q2 us-gaap Goodwill
Goodwill
18837000000
CY2022Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
26300000000
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
25600000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
CY2022Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.09
CY2021Q4 us-gaap Debt Current
DebtCurrent
1426000000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
110000000
CY2022Q2 teva Damages Assessment
DamagesAssessment
235500000
CY2021Q4 us-gaap Senior Notes
SeniorNotes
23118000000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1696000000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1403000000
CY2022Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
87000000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
100000000
CY2022Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
20363000000
CY2021Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
21617000000
CY2022Q2 teva Long Term Debt Currency Portion Usd
LongTermDebtCurrencyPortionUSD
0.63
CY2022Q2 teva Long Term Debt Currency Portion Eur
LongTermDebtCurrencyPortionEUR
0.34
CY2022Q2 teva Long Term Debt Currency Portion Chf
LongTermDebtCurrencyPortionCHF
0.03
CY2022Q2 teva Revenues Other Than Usd
RevenuesOtherThanUsd
0.48
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
493000000
CY2022Q2 teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
7000000
CY2021Q2 teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
8000000
teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
15000000
teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
16000000
CY2022Q2 teva Interest Rate Swap Loss
InterestRateSwapLoss
1000000
CY2021Q2 teva Interest Rate Swap Loss
InterestRateSwapLoss
1000000
teva Interest Rate Swap Loss
InterestRateSwapLoss
2000000
teva Interest Rate Swap Loss
InterestRateSwapLoss
1000000
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
729000000
CY2021Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
6000000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1854000000
teva Restructuring Expense And Income
RestructuringExpenseAndIncome
The expense in the first six months of 2021 was mainly due to the provision for the carvedilol patent litigation.
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3928000000
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
2710000000
CY2021Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
235500000
CY2021 teva Annual Sales Of Narcan
AnnualSalesOfNarcan
434000000
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
60500000
teva Annual Sales Of Effexor
AnnualSalesOfEffexor
2600000000
CY2005Q1 teva Annual Sales Of Lamictal
AnnualSalesOfLamictal
950000000000
CY2008Q3 teva Annual Sales Of Lamictal
AnnualSalesOfLamictal
2300000000
CY2013Q2 teva Annual Sales Of Niaspan
AnnualSalesOfNiaspan
416000000
CY2013Q3 teva Annual Sales Of Niaspan
AnnualSalesOfNiaspan
1100000000
CY2010Q4 teva Annual Sales Of Actos
AnnualSalesOfActos
3700000000
CY2010Q4 teva Annual Sales Of Actoplus
AnnualSalesOfActoplus
500000000
CY2012Q3 teva Annual Sales Of Actos
AnnualSalesOfActos
2800000000
CY2012Q3 teva Annual Sales Of Actoplus
AnnualSalesOfActoplus
430000000
CY2019 teva Annual Sales Of Sensipar
AnnualSalesOfSensipar
1400000000
CY2019Q3 teva Annual Sales At Time Of Settlement
AnnualSalesAtTimeOfSettlement
350000000
CY2020Q3 teva Annual Sales At Time Of Settlement
AnnualSalesAtTimeOfSettlement
700000000
CY2014 teva Annual Sales Of Copaxone
AnnualSalesOfCopaxone
373000000
CY2021Q2 teva Loss Contingency Claims Dismissed Value
LossContingencyClaimsDismissedValue
925000
CY2022Q1 teva Loss Contingency Claims Dismissed Value
LossContingencyClaimsDismissedValue
1450000
CY2022Q1 teva Percentage Of Population Of Subdivisions Will Formally Release As A Part Of Settlement
PercentageOfPopulationOfSubdivisionsWillFormallyReleaseAsAPartOfSettlement
96
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
420000000
CY2022Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
300000
CY2021Q3 teva Loss Contingencies On Environmental Laws Penalty
LossContingenciesOnEnvironmentalLawsPenalty
1400000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1160000000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
308000000
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
4200000000
CY2022Q2 teva Effective Income Tax Reconciliation Amount Inventory Written Off
EffectiveIncomeTaxReconciliationAmountInventoryWrittenOff
850000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-899000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2131000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
451000000
teva Expected Impairment Of Income Tax Benefit
ExpectedImpairmentOfIncomeTaxBenefit
133000000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
412000000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
414000000
CY2022Q2 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
118000000
CY2021Q2 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
28000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
246000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
94000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
16000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
165000000
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
35000000
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
-13000000
us-gaap Restructuring Charges
RestructuringCharges
92000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
CY2022Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
14000000
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
32000000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
30000000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
80000000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
61000000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
94000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
16000000
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
35000000
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
-13000000
us-gaap Restructuring Charges
RestructuringCharges
92000000
us-gaap Restructuring Charges
RestructuringCharges
69000000
CY2022Q2 teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
8000000
CY2021Q2 teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
28000000
teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
30000000
teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
33000000
CY2022Q2 teva Impairment And Restructuring
ImpairmentAndRestructuring
118000000
CY2021Q2 teva Impairment And Restructuring
ImpairmentAndRestructuring
28000000
teva Impairment And Restructuring
ImpairmentAndRestructuring
246000000
teva Impairment And Restructuring
ImpairmentAndRestructuring
165000000
CY2022Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
14000000
CY2021Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
32000000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
30000000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
80000000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
61000000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19000000
us-gaap Restructuring Charges
RestructuringCharges
69000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1108000000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
35000000
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
-13000000
us-gaap Restructuring Charges
RestructuringCharges
92000000
us-gaap Restructuring Charges
RestructuringCharges
69000000
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
138000000
teva Restructuring Accrual Provision
RestructuringAccrualProvision
92000000
teva Utilization And Other
UtilizationAndOther
103000000
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
127000000
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
122000000
teva Restructuring Accrual Provision
RestructuringAccrualProvision
69000000
teva Utilization And Other
UtilizationAndOther
64000000
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
127000000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73000000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1110000000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
-9000000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
212000000
teva Bifurcated Embedded Derivatives
BifurcatedEmbeddedDerivatives
0
CY2022Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
51000000
CY2021Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
195000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
199000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
274000000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
204000000
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
204000000
CY2022Q2 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
729000000
CY2021Q2 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
6000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
1854000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
110000000
CY2022Q2 teva Other Unallocated Amounts
OtherUnallocatedAmounts
113000000
CY2021Q2 teva Other Unallocated Amounts
OtherUnallocatedAmounts
50000000
teva Other Unallocated Amounts
OtherUnallocatedAmounts
240000000
teva Other Unallocated Amounts
OtherUnallocatedAmounts
132000000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-949000000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
582000000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1662000000
us-gaap Operating Income Loss
OperatingIncomeLoss
1015000000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-211000000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-274000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-468000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-564000000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1160000000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
308000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2131000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
451000000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
33000000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
205000000
CY2022Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
1934000000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
33000000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
176000000
CY2021Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
2054000000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
175000000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
258000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0
CY2022Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
19183000000
CY2021Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
22903000000

Files In Submission

Name View Source Status
0001193125-22-203392-index-headers.html Edgar Link pending
0001193125-22-203392-index.html Edgar Link pending
0001193125-22-203392.txt Edgar Link pending
0001193125-22-203392-xbrl.zip Edgar Link pending
d360666d10q.htm Edgar Link pending
d360666d10q_htm.xml Edgar Link completed
d360666dex311.htm Edgar Link pending
d360666dex312.htm Edgar Link pending
d360666dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
teva-20220630.xsd Edgar Link pending
teva-20220630_cal.xml Edgar Link unprocessable
teva-20220630_def.xml Edgar Link unprocessable
teva-20220630_lab.xml Edgar Link unprocessable
teva-20220630_pre.xml Edgar Link unprocessable